What are the diagnostic criteria and treatment options for a patient with suspected fibromyalgia?

Fibromyalgia Diagnosis

Fibromyalgia is diagnosed clinically when a patient has widespread pain in all four body quadrants for at least 3 months, though the modern approach no longer requires the traditional 11 of 18 tender point examination. 1, 2

Diagnostic Criteria

American College of Rheumatology Approach

• The diagnosis requires widespread pain for ≥3 months plus assessment of symptom severity, including pain locations, fatigue intensity, sleep quality, and cognitive symptoms 2, 3
• The traditional 1990 criteria required pain on palpation (approximately 4 kg pressure) in at least 11 of 18 specific tender points, but newer criteria have moved away from this requirement 1, 4
• Fibromyalgia represents abnormal central pain processing (central sensitization) rather than peripheral tissue damage or inflammation, which fundamentally distinguishes it from inflammatory rheumatic diseases 2, 5

Clinical Assessment Components

• Evaluate pain intensity across multiple body regions, functional limitations in daily activities, sleep quality and restorative nature, fatigue severity, cognitive symptoms ("fibro fog"), and psychosocial factors including depression and anxiety 2
• Normal laboratory results support rather than exclude the diagnosis—fibromyalgia involves no organic tissue damage 1
• Screen for comorbid conditions including irritable bowel syndrome, chronic fatigue syndrome, migraine, depression, and anxiety disorders 3, 4

Screening Tool

• The Fibromyalgia Rapid Screening Tool is helpful for patients presenting with diffuse chronic pain 3

Common Diagnostic Pitfalls

• Fibromyalgia is not a diagnosis of exclusion—it has positive diagnostic criteria and should be diagnosed affirmatively when criteria are met 6
• Avoid extensive laboratory testing and imaging beyond what is needed to rule out inflammatory or systemic diseases based on history and physical examination 7
• Do not delay diagnosis waiting for "all other possibilities" to be excluded, as this leads to the typical >2 years and 3.7 physician consultations before diagnosis 8

---

Treatment Algorithm for Fibromyalgia

Stage 1: Initial Management (First-Line)

Patient Education

• Immediately provide education about central sensitization and the chronic nature of fibromyalgia, explaining that pain arises from altered brain processing rather than tissue damage 1, 2

Exercise (Strongest Evidence)

• Begin aerobic and strengthening exercise as the primary intervention—this has the only "strong for" recommendation with 100% expert agreement 8, 9, 2
• Start with low-impact aerobic exercise (walking, swimming, cycling) at 20-30 minutes, 2-3 times weekly 2
• Gradually increase to 30-60 minutes, 5 days weekly over 4-8 weeks 2
• Add progressive resistance training 2-3 times weekly once aerobic tolerance is established 2
• Heated pool therapy or hydrotherapy provides additional benefit and may improve exercise tolerance 9, 2

Reassessment Timeline

• Evaluate response after 4-6 weeks using pain scores (0-10 scale), functional status, and patient global impression of change 9, 2

Stage 2: Additional Non-Pharmacological Therapies

If insufficient response after 4-6 weeks of exercise, add the following based on individual symptom profile:

For Mood Disorders and Maladaptive Coping

• Cognitive behavioral therapy (CBT) is recommended particularly for patients with depression, anxiety, or unhelpful coping strategies (Level Ia, Grade A) 8, 9, 2

For Additional Pain Relief

• Acupuncture provides pain reduction (Level Ia, Grade A) 2
• Meditative movement therapies including tai chi, yoga, or qigong (Level Ia, Grade A) 9, 2
• Mindfulness-based stress reduction programs 2

Multicomponent Approach

• Combining exercise, CBT, and other therapies may provide greater benefit than any single intervention 9, 2

Stage 3: Pharmacological Management (Second-Line)

Add medication only if non-pharmacological interventions provide insufficient relief after 4-6 weeks. 9, 1

First-Line Medication Options

Choose based on predominant symptom profile:

For Prominent Sleep Disturbance + Pain

• Amitriptyline 10 mg at bedtime, increase by 10 mg weekly to target 25-50 mg nightly (maximum 75 mg) 9, 1, 2
• Number needed to treat for 50% pain relief is 4.1 1
• Therapeutic effects emerge over 3-7 weeks 1
• Caution in older adults (≥65 years) due to anticholinergic effects (dry mouth, orthostatic hypotension, constipation, urinary retention, morning sedation) 9, 1

For Pain + Depression/Anxiety

• Duloxetine 30 mg daily for 1 week, then increase to 60 mg daily 9, 1, 2
• Approximately 50% of patients achieve ≥30% pain reduction 9
• Do not escalate beyond 60 mg/day—no additional benefit but increased adverse events 9

For Predominant Pain Without Mood Symptoms

• Pregabalin 75 mg twice daily, titrate to 150 mg twice daily over 1 week (target 300-450 mg/day total) 9, 1, 2
• Patients are more likely to achieve 30% pain reduction (RR 1.38,95% CI 1.25 to 1.51) 9
• Do not escalate beyond 450 mg/day—no additional benefit but increased adverse events 9
• Adjust dose for creatinine clearance <60 mL/min as pregabalin is renally eliminated 9

Alternative First-Line Option

• Milnacipran 100-200 mg/day in divided doses, titrate over approximately 1 week starting at lower doses 9, 1
• Similar efficacy to duloxetine for pain reduction and provides benefits for fatigue 9

Second-Line Medication Options

Cyclobenzaprine

• Consider for pain management, though side effects are common (85% experience adverse effects) 8
• Improves sleep more than pain 8

Tramadol

• Consider only when first-line medications are ineffective 9, 1
• Use with caution given opioid-related risks 9, 1

Monitoring and Adjustment

• Reassess every 4-8 weeks using pain scores, functional status, and side effects 9, 2
• Expect 30-50% pain reduction rather than complete resolution—most treatments show modest effect sizes 2
• If partial relief with one medication, consider adding another first-line medication from a different class 9
• If no relief at target dosage after adequate trial, switch to alternative first-line medication 9

Stage 4: Multimodal Rehabilitation

For severe disability despite above interventions, consider multimodal rehabilitation program combining exercise, psychological therapies, and pharmacotherapy 8

---

Critical Medications to AVOID

Strong Contraindications

• Corticosteroids have no role in fibromyalgia treatment—no efficacy demonstrated 9, 1, 2
• Strong opioids (morphine, oxycodone, hydrocodone) are not recommended—they lack demonstrated benefit and carry significant risks including dependence, tolerance, and worsening of central sensitization 9, 1, 2, 3

Limited or No Benefit

• NSAIDs (ibuprofen, naproxen) have limited to no benefit as monotherapy since fibromyalgia is not an inflammatory condition 9, 2, 3
• Simple analgesics like acetaminophen have limited evidence 9

---

Key Clinical Pearls

Understanding Treatment Expectations

• The effect size for most treatments is relatively modest—set realistic expectations with patients 8, 2
• Only about 1 in 4 patients achieves substantial benefit from amitriptyline (NNT 4.1) 1
• Approximately 50% achieve ≥30% pain reduction with duloxetine or pregabalin 9

Common Pitfalls to Avoid

• Do not rely solely on pharmacological therapy without implementing exercise and behavioral approaches—exercise has the strongest evidence 2
• Do not delay diagnosis with excessive testing—this leads to high healthcare utilization for up to 10 years prior to diagnosis 8
• Do not prescribe medications before attempting non-pharmacological interventions 8, 9
• Avoid combining medications with identical mechanisms (e.g., gabapentin + pregabalin bind to identical targets) 1

Long-Term Management

• Long-term management requires ongoing exercise maintenance and periodic reassessment of medication need 2
• Continue non-pharmacological therapies even when medications are added 8, 9